Resmed (RSMDF) Prepaid Assets (2010 - 2026)
Resmed's (RSMDF) quarterly Prepaid Assets came in at $416.1 million in Q2 2026, down 3.0% on a YoY basis from $429.0 million in Q2 2025, and down 15.57% quarter-over-quarter from $492.8 million in Q1 2026.
Analysis
Resmed (RSMDF) Prepaid Assets (2010 - 2026) Analysis & Trends
Resmed (RSMDF) has reported Prepaid Assets for 17 consecutive years, with $416.1 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Prepaid Assets fell 3.0% year-over-year to $416.1 million; the trailing twelve-month figure through Jun 2026 stood at $416.1 million (down 3.0% YoY), and the FY2026 full-year result was $416.1 million, down 3.0% from the prior year.
- Prepaid Assets retreated to $416.1 million in Q2 2026 per RSMDF's latest filing, from $492.8 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $572.2 million in Q4 2024 and bottomed at $220.1 million in Q1 2022.
- Historically, Prepaid Assets has averaged $436.5 million across 5 years, with a median of $440.9 million in 2023.
- The sharpest annual moves came in 2022 and 2025: Prepaid Assets soared 182.57% in 2022, then fell 19.93% in 2025.
- Over 5 years, Prepaid Assets stood at $410.7 million in 2022, then increased by 22.92% to $504.9 million in 2023, then rose by 13.33% to $572.2 million in 2024, then slipped by 13.66% to $494.1 million in 2025, then retreated by 15.78% to $416.1 million in 2026.
- According to Business Quant data, Prepaid Assets over the past three periods registered $416.1 million, $492.8 million, and $494.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.57 Bn | 178.97 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 124.13 Bn | 118.91 Bn | 1.96 Bn |
| 3 | Medtronic | 118.29 Bn | 109.47 Bn | 6.34 Bn |
| 4 | Stryker | 104.60 Bn | 101.12 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.50 Bn | 65.97 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.72 Bn | 45.46 Bn | 1.35 Bn |
| 7 | Alcon | 33.97 Bn | 32.51 Bn | 1.68 Bn |
| 8 | Dexcom | 32.23 Bn | 30.29 Bn | 830.00 Mn |
| 9 | Steris | 21.16 Bn | 20.68 Bn | 684.20 Mn |
| 10 | Resmed | 3.54 Bn | 2.07 Bn | 861.22 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 416.08 Mn |
| Mar 31, 2026 | 492.84 Mn |
| Dec 31, 2025 | 494.05 Mn |
| Sep 30, 2025 | 388.81 Mn |
| Jun 30, 2025 | 428.95 Mn |
| Mar 31, 2025 | 505.24 Mn |
| Dec 31, 2024 | 572.19 Mn |
| Sep 30, 2024 | 485.58 Mn |
| Jun 30, 2024 | 459.83 Mn |
| Mar 31, 2024 | 504.66 Mn |
| Dec 31, 2023 | 504.88 Mn |
| Sep 30, 2023 | 444.86 Mn |
| Jun 30, 2023 | 437.02 Mn |
| Mar 31, 2023 | 412.39 Mn |
| Dec 31, 2022 | 410.73 Mn |
| Sep 30, 2022 | 341.20 Mn |
| Jun 30, 2022 | 337.91 Mn |
| Mar 31, 2022 | 220.11 Mn |
| Dec 31, 2021 | 145.35 Mn |
| Sep 30, 2021 | 150.08 Mn |